​EU MDR: REQUIREMENTS & IMPLEMENTATION

THIS EVENT WAS RECORDED JULY 17, 2019  

This on-demand recording of the four-hour virtual event that took place July 17, 2019, conducted by leading experts on EU MDR requirements and implementation, provides concise insights into key aspects of the regulation to help companies understand and plan for the impending changes. 

The EU Medical Device Regulation (EU MDR) require more than a few new SOPs. A profound overhaul of the regulatory approach in one of the world’s largest medical device markets, the EU MDR demands new procedures, evidence development, documentation, relationships, reporting, data management, and a reevaluation of legacy portfolios. Senior management should be involved in strategic planning for changes that can significantly affect a company’s business.

This four-hour virtual conference recording, conducted by leading experts on EU MDR requirements and implementation, provides concise insights into key aspects of the regulation to help companies understand and plan for the impending changes.

 

What you will learn:

 

• EU MDR provisions and timeline

• Strategic considerations and priorities

• The business impact of compliance

• New clinical evidence requirements

• Changes in postmarket surveillance

• Requirements for economic operators

• Supply chain considerations

• Labeling, IFU, and UDI requirements

• Risk management provisions

• Eudamed database reporting requirements

• Remediation of legacy devices

 

Target Audiences:

• Senior management
• RA/QA
• Clinical
• Postmarket
• Compliance
• Legal
• Supply Chain
• Global strategy


 

 

 

 

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top